Free shipping on all orders over $ 500

KR-33493

Cat. No. M7532

All AbMole products are for research use only, cannot be used for human consumption.

KR-33493 Structure
Size Price Availability
5mg USD 100 4-7 Days
10mg USD 150 4-7 Days
50mg USD 450 4-7 Days
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Body weight changes of both sexes are not related to KR-33493 in all doses. In rats administrated KR-33493 for 4 weeks, no test article-related changes in any treated groups of either sex are found in hematology, serum biochemistry, and urinalysis. In dogs administrated KR-33493 for 2 weeks, red blood cell count (RBC) value in males is significantly higher at the 1000 mg/kg/day dose than that of the control group (i.e., 6.96±0.323 vs. 6.12±0.418). However, the change of RBC is recovered after the end of the administration period. The dose-normalized AUClast is not significantly different between the groups, suggesting that KR-33493 is governed by linear kinetics

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models specific pathogen-free rats
Formulation
Dosages 50, 150, and 500 mg/kg/day
Administration i.v.
Chemical Information
Molecular Weight 460.34
Formula C20H18BrN3O3S
CAS Number 1021497-97-1
Form Solid
Solubility (25°C) 31 mg/mL in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jeong JW, et al. Regul Toxicol Pharmacol. Subacute toxicity evaluation of KR-33493, FAF1 inhibitor for a new anti-parkinson's disease agent, after oral administration in rats and dogs.

[2] Yoo SE, et al. Bioorg Med Chem Lett. Design and synthesis of fluorescent and biotin tagged probes for the study of molecular actions of FAF1 inhibitor.

Related TNF Receptor Products
Lenalidomide

Lenalidomide is a thalidomide analog known to display TNF-α secretion inhibition and possesses immunomodulatory properties.

Atrosab

Atrosab is a humanized IgG1 antagonistic anti-TNFR1 antibody. Atrosab inhibits TNF-mediated Apoptosis induction and IL-6 and IL-8 production. Atrosab reduces neurological deficits.

Infliximab

Infliximab is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody that blocks TNF-α interaction with TNF-α receptor 1 (TNFR1) and TNFR2. For the treatment of autoimmune diseases. Infliximab is available in BALB/ C or C57/Bl6 mice.

Mesaconitine

Mesaconitine is the main active ingredient of Aconitum and has many pharmaceutical effects.

Hypaconitine

Hypaconitine is a highly toxic natural active ingredient isolated from aconitum species, which is widely used to study rheumatism.

  Catalog
Abmole Inhibitor Catalog




Keywords: KR-33493 supplier, TNF Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.